Retatrutide Pen Guide

What Is a Retatrutide Pen?

A retatrutide pen is a prefilled, multi-dose subcutaneous injection device containing retatrutide in a ready-to-use liquid formulation. Unlike traditional vials that require reconstitution from lyophilised powder, the pen comes pre-loaded and uses a click-based dial mechanism for precise dose selection. Each click of the dial dispenses exactly 0.1mg of retatrutide.

Retatrutide (LY3437943) is a triple-agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon receptor). This triple mechanism of action is the basis for its efficacy in Phase 2 clinical trials, where the highest dose produced a 24.2% mean body weight reduction over 48 weeks. Retatrutide is currently in Eli Lilly’s Phase 3 TRIUMPH clinical trial program and has not yet received regulatory approval—see our retatrutide approval status tracker for the latest timeline.

The pen format is particularly suited to research protocols that require repeated, precisely metered doses over multi-week titration schedules. The Remy Peptides Retatrutide 30mg Pen contains enough material for a complete titration from starting doses through maintenance in a single device. A 20mg pen variant is also available for lower-volume protocols.

What Are the Retatrutide Pen Specifications?

The Remy Peptides Retatrutide pen is a 30mg prefilled FlexiPen with the following technical specifications.

The 60-click maximum per single administration is a mechanical safety feature of the dial. For doses exceeding 6mg, two separate administrations from the same pen are required—for example, a 10mg dose would be delivered as two 50-click (5mg) administrations or a 60-click (6mg) plus 40-click (4mg) split. Our retatrutide dosage and titration guide covers the full clinical titration protocol.

How Do You Use a Retatrutide Pen?

Using a retatrutide pen follows the same general procedure as other prefilled subcutaneous pen injectors. The full process takes approximately 5 minutes.

Step 1 — Prepare the Pen

Remove the pen from the refrigerator 15–30 minutes before use to allow it to reach room temperature. Inspect the solution through the viewing window—it should be clear and colourless with no visible particles or cloudiness. Do not use a pen with discoloured or particulate-containing solution.

Step 2 — Attach the Needle

Peel the paper seal from a new, single-use pen needle. Screw or push the needle straight onto the pen tip until it is secure. Remove the outer needle cap (keep it for disposal) and the inner needle cap (discard). Use a fresh needle for every administration—never reuse pen needles.

Step 3 — Prime the Pen

Priming removes air bubbles from the cartridge and ensures accurate dosing. Dial 2 clicks (0.2mg) on the dose selector. Hold the pen with the needle pointing upward, tap the cartridge gently to move any air bubbles to the top, and press the plunger button until a drop of liquid appears at the needle tip. If no drop appears, repeat the priming step. Prime before each new needle attachment.

Step 4 — Select the Dose

Turn the dose dial to the required number of clicks. Each click equals 0.1mg. The dial can be turned in either direction, so overdials can be corrected without wasting material. The maximum setting is 60 clicks (6mg) per administration.

For the complete titration schedule matching the Phase 2 clinical trial protocol, see our dosage guide and dose calculator.

Step 5 — Administer the Dose

Clean the injection site with an alcohol swab. Pinch the skin if using a needle longer than 5mm. Insert the needle at a 90-degree angle into the subcutaneous tissue of the abdomen, thigh, or upper arm. Press the plunger button fully and hold in place for 10 seconds to ensure the complete dose is delivered. A longer hold time reduces the chance of medication leaking at the injection site.

Step 6 — Remove, Dispose, and Store

Withdraw the needle from the skin. Carefully twist or pull the needle off the pen and dispose of it immediately in a sharps container. Replace the pen cap and return the pen to storage. For information on safe injection practices and managing injection-site reactions, see our retatrutide side effects guide.

How Many Doses Are in a Retatrutide Pen?

The Remy Peptides Retatrutide pen contains 30mg total, which is divided into 300 clicks at 0.1mg each. The number of weekly doses you get from a single pen depends entirely on your weekly dose.

Note: The pen has a 28-day use window after first administration. At very low starting doses (0.5–1mg/week), the 28-day window will expire before the pen is fully depleted. Factor this into your protocol planning.

Full Titration in a Single Pen

A complete Phase 2 titration from 0.5mg to 12mg/week spans approximately 24 weeks. During the initial escalation phase (weeks 1–12 at lower doses), a single 30mg pen covers the first 15+ weeks of material. Here is the approximate usage for a standard titration start:

• Weeks 1–4 at 0.5mg/week: 2.0mg used (20 clicks)
• Weeks 5–8 at 1.0mg/week: 4.0mg used (40 clicks)
• Weeks 9–12 at 2.0mg/week: 8.0mg used (80 clicks)
• Weeks 13–16 at 4.0mg/week: 16.0mg used (160 clicks)
• Running total: 30mg (300 clicks) — one pen covers the first 16 weeks of titration

After the first pen is depleted, you would begin a second pen for the higher maintenance doses (8–12mg/week). The dose calculator can model your exact protocol and show how many pens you need.

Retatrutide Pen vs Vial — Which Is Better?

Retatrutide is available in two formats: prefilled pens and lyophilised powder vials. Each has trade-offs depending on the research application.

For most research protocols, the pen format offers the best balance of accuracy, convenience, and contamination control. The vial format may be preferred when cost per milligram is the primary consideration or when researchers need to prepare custom concentrations. For a broader comparison of retatrutide against other compounds, see our retatrutide vs tirzepatide comparison.

How Should a Retatrutide Pen Be Stored?

Proper storage is critical for maintaining peptide integrity and ensuring consistent research results. Retatrutide is a peptide that degrades when exposed to heat, light, or repeated freeze-thaw cycles.

Before First Use

• Store at 2–8°C (standard refrigerator temperature)
• Do not freeze — freezing can damage the peptide structure and the pen mechanism
• Keep in original packaging to protect from light
• Store upright if possible

After First Use

• Can be stored at room temperature (up to 25°C) or returned to the refrigerator
• 28-day use window — discard the pen 28 days after the first dose, regardless of remaining content
• Do not expose to temperatures above 30°C
• Avoid direct sunlight or prolonged UV exposure
• Always remove the needle after each use to prevent contamination and leakage

For detailed information on peptide degradation rates and optimal storage conditions, see our peptide stability and storage guide. In hot climates such as the UAE (where ambient temperatures regularly exceed 45°C), temperature-controlled transport and refrigerated storage are especially important.

What Needles Are Compatible with a Retatrutide Pen?

The Remy Peptides retatrutide pen uses standard pen needles that are universally compatible with most prefilled pen injectors. Pen needles are sold separately and should be single-use only.

Key needle rules: Always use a new needle for each administration. Never leave a needle attached to the pen between uses—this can cause air entry, contamination, and medication leakage. Dispose of used needles in a proper sharps container immediately after use.

How Is Retatrutide Pen Purity Verified?

Every batch of Remy Peptides retatrutide is independently tested by Janoshik Analytical, a third-party laboratory that provides HPLC (High-Performance Liquid Chromatography) purity analysis for peptide suppliers worldwide.

• Batch: RETP002
• Purity: 99.262% by HPLC
• Method: Reversed-phase HPLC with UV detection
• Lab: Janoshik Analytical (independent, not affiliated with Remy Peptides)

The full Certificate of Analysis (COA) for batch RETP002 is published on our COA verification page, where you can view the chromatogram, retention times, and impurity profile. HPLC purity above 99% is considered research-grade—the 99.262% result places this batch in the top tier of commercially available retatrutide.

We publish every COA because transparency is the only reliable quality signal in the research peptide market. If a supplier does not publish third-party lab results, the purity claim cannot be independently verified. For more on evaluating peptide quality, see our retatrutide buying guide.

How Much Does a Retatrutide Pen Cost?

Remy Peptides offers tiered pricing for the 30mg Retatrutide pen, with per-pen cost decreasing at higher quantities.

All orders include a Janoshik-verified Certificate of Analysis, temperature-controlled delivery, and WhatsApp support at +34 672 737 521. For bulk orders beyond the 5-pack tier or institutional procurement, contact us via Telegram at @propeptide.

When evaluating retatrutide pen price, the key metric is cost per milligram. At the 5-pack tier, the Remy Peptides pen delivers 30mg of 99.262%-pure retatrutide at AED 33.33/mg. This compares to unverified vial powder that may cost less per milligram but carries unknown purity risk without published third-party lab data.